Authors
Loading...
Literature review reveals shared genetic susceptibility loci across inflammatory bowel disease and complex disorders, highlighting common biological pathways for targeted therapeutics.
Lees et al. (2011) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: